NCT04381182 is a NA clinical trial of Apollo Wearable Device in Stress, sponsored by Joseph Maroon.

Who is sponsoring NCT04381182?

NCT04381182 is sponsored by Joseph Maroon.

What drugs are being tested in NCT04381182?

Interventions in NCT04381182: Apollo Wearable Device.

What condition does NCT04381182 study?

NCT04381182 studies Stress, Heart Rate Variability.

Is NCT04381182 still recruiting?

NCT04381182 is currently terminated. Last updated 6 December 2022.

Last reviewed 2022-12-06 · How we verify

NCT04381182

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Heart Rate Variability and Stress Management Enhancement

Terminated NA Last updated 6 December 2022

What this trial tests

NA trial testing Apollo Wearable Device in Stress in 20 participants. Terminated before completion.

Timeline

1 September 2021

Primary endpoint
20 July 2022

20 August 2022

Quick facts

Lead sponsor	Joseph Maroon
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	20
Start date	1 September 2021
Primary completion	20 July 2022
Estimated completion	20 August 2022
Sites	1 location across United States

Drugs / interventions tested

Apollo Wearable Device

Conditions studied

Stress — all drugs for Stress →
Heart Rate Variability — all drugs for Heart Rate Variability →

Sponsor

Joseph Maroon

Who can join

Eligibility, any sex, with Stress or Heart Rate Variability. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will be conducted by using two devices (Apollo and Biostrap) for monitoring of baseline physiologic variables and heart rate variability. The biostrap will be worn by residents and will monitor heart rate, heart rate variability, respiratory rate, sleep patterns, steps, etc. The Apollo is a pulse generator device aimed at modulating heart rate variability for (hopefully) reduction in stress and improving performance in and around the hospital. Resident neurosurgeons will wear the biostrap for a two week cycle and follow that with the addition of the Apollo device for heart rate variability modulation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Stress

Currently open trials in the same condition.

NCT07485790 — The Effects of Yoga on Pregnant Women · NA · recruiting
NCT07469527 — Effects of Feel Free® Classic Tonic on Stress and Pharmacokinetics in Healthy Adults · NA · recruiting
NCT07387107 — Decreasing Stress Via Virtual Reality and Binaural Beats in Non-Clinical Adults · NA · recruiting
NCT07240792 — Development of a College Student-Delivered Cognitive-Behavioral Therapy (CBT) Intervention for Rural High School Student · NA · recruiting
NCT07518056 — Relationships Between Nomophobia Levels and Perceived Stress, Body Image and Food Addiction Among University Students · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04381182 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Joseph Maroon
Last refreshed: 6 December 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04381182.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing